Home › NDC Lookup › RxCUI directory › RxCUI 1592285

Pirfenidone 267 MG Oral Capsule [Esbriet] — RxCUI 1592285

RxNorm drug concept · Semantic branded drug
RxCUI 1592285 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1592285
Official namePirfenidone 267 MG Oral Capsule [Esbriet]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asEsbriet 267 MG Oral Capsule
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pirfenidone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Pirfenidone is used specifically to treat idiopathic pulmonary fibrosis — or IPF — a condition where the lungs gradually develop scar tissue, making breathing harder over time. It'...
  • What exactly is pirfenidone used for, and how does it help?
  • Yes — it really does matter. You should always take pirfenidone with food, every time. Taking it on an empty stomach raises the peak level of the drug in your blood too quickly, wh...
  • The most common ones — especially in the first few months — are nausea, stomach pain, diarrhea, decreased appetite, fatigue, and rash. Most of these tend to ease up over time, and...
📖 Read our full Pirfenidone guide →

🕸️ Concept Web — How Pirfenidone 267 MG Oral Capsule [Esbriet] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pirfenidone 267 MG Oral Capsule [Esbriet] RxCUI 1592285

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Pirfenidone 1592254
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Esbriet 1592280
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pirfenidone Oral Capsule 1592278
    • Pirfenidone Oral Product 1592276
    • Pirfenidone Pill 1592277
    • Pirfenidone Oral Capsule [Esbriet] 1592282
    • Esbriet Oral Product 1592283
    • Esbriet Pill 1592284
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Pirfenidone 267 MG [Esbriet] SBDC · 1592281
  • Pirfenidone Oral Capsule [Esbriet] SBDF · 1592282
  • Esbriet Oral Product SBDG · 1592283
  • Esbriet Pill SBDG · 1592284
  • Esbriet BN · 1592280

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1592285 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50242-0122-06 1 BOTTLE, PLASTIC in 1 CARTON (50242-122-06) / 270 TABLET,... ESBRIET Genentech, Inc. 2018-01-22
50242-0123-01 1 BOTTLE, PLASTIC in 1 CARTON (50242-123-01) / 90 TABLET, C... ESBRIET Genentech, Inc. 2017-01-11
Observed labelers: Genentech, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.